Prostate Cancer
USC Team Counts Circulating Tumor Cells to Predict Treatment Response, Survival in Prostate Cancer
Premium
The researchers used the CellSearch assay to measure circulating tumor cells and determine the response to certain treatments as well as survival outcomes.
Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium
The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer.
The firm last week announced it received funding that will allow it to complete development of the test, called Myelo-Scan, by the end of 2026.
Nanostics Signs on OncoHelix to Offer Prostate Cancer Risk Tool in Middle East
The deal comes on the heels of a similar arrangement Nanostics struck with Protean BioDiagnostics for the US market.
Kairos Pharma, PreCheck Health Services to Develop CDx for Prostate, Lung Cancer Drug
PreCheck will help the biopharma firm confirm and validate biomarkers previously identified in early-phase trials for companion diagnostic use.